<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31699893</article-id>
<article-id pub-id-type="pmc">6916470</article-id>
<article-id pub-id-type="publisher-id">AW119.008137</article-id>
<article-id pub-id-type="doi">10.1074/jbc.AW119.008137</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>ASBMB Award Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The neural stem cell/carnitine malnutrition hypothesis: new prospects for effective reduction of autism risk?</article-title>
<alt-title alt-title-type="short">ASBMB AWARD ARTICLE: Neural stem cell carnitine malnutrition and autism risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-1654-6759</contrib-id>
<name>
<surname>Bankaitis</surname>
<given-names>Vytas A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>¶</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Zhigang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
</contrib>
<aff id="aff1"><label>‡</label>Department of Molecular and Cellular Medicine, Texas A&amp;M University Health Science Center, College Station, Texas 77843-1114</aff>
<aff id="aff2"><label>§</label>Department of Biochemistry and Biophysics, Texas A&amp;M University Health Science Center, College Station, Texas 77843-1114</aff>
<aff id="aff3"><label>¶</label>Department of Chemistry, Texas A&amp;M University Health Science Center, College Station, Texas 77843-1114</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> To whom correspondence should be addressed. Tel.:
<phone>979-436-0757</phone>; E-mail: <email>vytas@tamu.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Dennis R. Voelker</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>13</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>7</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>7</day>
<month>11</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>294</volume>
<issue>50</issue>
<fpage>19424</fpage>
<lpage>19435</lpage>
<permissions>
<copyright-statement>© 2019 Bankaitis and Xie.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Bankaitis and Xie.</copyright-holder>
<license>
<license-p>Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc05019019424.pdf"></self-uri>
<abstract>
<p>Autism spectrum disorders (ASDs) are developmental neuropsychiatric disorders with heterogeneous etiologies. As the incidence of these disorders is rising, such disorders represent a major human health problem with escalating social cost. Although recent years witnessed advances in our understanding of the genetic basis of some dysmorphic ASDs, little progress has been made in translating the improved understanding into effective strategies for ASD management or minimization of general ASD risk. Here we explore the idea, described in terms of the neural stem cell (NSC)/carnitine malnutrition hypothesis, that an unappreciated risk factor for ASD is diminished capacity for carnitine-dependent long-chain fatty acid β-oxidation in neural stem cells of the developing mammalian brain. The basic premise is that fetal carnitine status is a significant metabolic component in determining NSC vulnerability to derangements in their self-renewal program and, therefore, to fetal ASD risk. As fetal carnitine status exhibits a genetic component that relates to <italic>de novo</italic> carnitine biosynthesis and is sensitive to environmental and behavioral factors that affect maternal circulating carnitine levels, to which the fetus is exposed, we propose that reduced carnitine availability during gestation is a common risk factor that lurks beneath the genetically complex ASD horizon. One major prediction of the NSC/carnitine malnutrition hypothesis is that a significant component of ASD risk might be effectively managed from a public policy perspective by implementing a carnitine surveillance and dietary supplementation strategy for women planning pregnancies and for women in their first trimester of pregnancy. We argue that this prediction deserves serious clinical interrogation.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>fatty acid oxidation</kwd>
<kwd>stem cells</kwd>
<kwd>nutrition</kwd>
<kwd>genetic disease</kwd>
<kwd>neural stem cells</kwd>
<kwd>carnitine</kwd>
<kwd>neocortex</kwd>
<kwd>neuronal development</kwd>
<kwd>prevention</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>Robert A. Welch Foundation</funding-source>
<award-id>BE-0117</award-id>
<principal-award-recipient>
<name>
<surname>Bankaitis</surname>
<given-names>Vytas A.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>